期刊文献+

宫颈癌组织中MCM-2、Notch1的表达变化及意义 被引量:2

下载PDF
导出
摘要 目的观察宫颈癌组织中微小染色体维持蛋白2(MCM-2)、Notch1蛋白的表达变化,并探讨其意义。方法采用免疫组化法检测78例宫颈癌组织(癌症组)及20例正常宫颈组织(对照组)中的MCM-2、Notch1蛋白。结果癌症组MCM-2蛋白阳性67例、Notch1蛋白阳性63例,对照组分别为5、3例;两组比较,P均<0.05。MCM-2、Notch1蛋白表达与宫颈癌分化程度、临床分期及淋巴结转移有关(P均<0.05)。宫颈癌组织中,MCM-2、Notch1蛋白表达呈正相关(r=0.702,P<0.01)。结论宫颈癌组织中MCM-2、Notch1蛋白表达升高,二者在宫颈癌的发生发展中发挥一定作用。
机构地区 郑州人民医院
出处 《山东医药》 CAS 2012年第2期80-81,共2页 Shandong Medical Journal
  • 相关文献

参考文献8

  • 1Jemal A, Siegel R, Xu J,et al. Cancer statistics, 2010[J]. CA Cancer J Clin,2011,60(5) :277-300.
  • 2栗东海,赵全年,王宁.微小染色体维持蛋白2在肿瘤中的研究现状[J].医学综述,2010,16(19):2945-2947. 被引量:5
  • 3Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-trans-formed cells [J]. Nat Med,2002,8(6) : 979-986.
  • 4Gonzalez MA, Pinder SE, Callagy G, et al. Minichromosome mainte- nance protein 2 is a strong independent prognostic marker in breast cancer[J]. J Clin 0ncol,2003,21 (23):4306-4313.
  • 5蒲红伟,李晓梅,古力娜尔.库尔班,刘霞,陈晓.食管鳞状细胞癌中MCM-2和Grp-94的表达及其临床病理学意义研究[J].河北职工医学院学报,2008,25(5):14-17. 被引量:1
  • 6Bolos V, Grego-Bessa J, de Pompa JL. Notch Signaling in Develop- ment and Cancer [ J ]. Endocr Rev, 2007,28 ( 3 ) : 339 -363.
  • 7Koch U, Radtke F. Notch and cancer:a double-edged sword [ J]. Cell Mol Life Sci,2007,21 (12) :2746-2762.
  • 8Nicolas M, Wolfer A, Raj K, et al. Notchl functions as a tumor suppressor in mouse skin[J]. Nat Genet,2003,3(2) :416421.

二级参考文献22

共引文献4

同被引文献31

  • 1Kang YH, Galal WC, Farina A, et al. Properties of the human Cdc45/Mcm2-7/GINS helicase complex and its action with DNA polymerase epsilon in roiling circle DNA synthesis [J].Proc Natl Acad Sci USA ,2012,109(16) :6042-6047.
  • 2Rusiniak ME, Kunnev D, Freeland A, et al. Mcm2 deficiency re- suits in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma [J].Oncogene,2012,31 (36): 4034-4044.
  • 3Boos D, Frigola J, Diffley JF. Activation of the replicative DNA he- licase: breaking up is hard to do [J].Curr Opin Cell Biol,2012,24 (3) : 423-430.
  • 4Forsburg SL. The MCM helicase:linking checkpoints to the replica- tion fork[J]. Biochem Soc Trans, 2008,36 (Ptl) : 114-119.
  • 5Yang C, Wen Y, Li H, et al. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer[J]. Oncol Rep, 2012,27 ( 1 ) : 135-142.
  • 6Wojnar A, Pula B, Piotrowska A, et al. Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma[J]. Anticancer Res, 2011,31 (9) : 3027-3033.
  • 7Saeb-Parsy K, Wilson A, Scarpini C, et al. Diagnosis of bladder cancer by immunocytochemical detection of minichromosome mainte- nance protein-2 in cells retrieved from urine [J]. Br J Cancer, 2012,107(8) : 1384-1391.
  • 8Ishimi Y, Okayasu I, Kato C, etal. Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix [J]. Eur J Biochem, 2003,270(6) .. 1089-1101.
  • 9Williams GH, Romanowski P, Morris L, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication[J].Proc Natl Acad Sci USA, 1998,95 (25) : 14932- 14937.
  • 10Mukherjee G, Muralidhar B, Bafna UD, et al. Mcm immunocyto- chemistry as a first line cervical screening test in developing coun- tries: a prospective cohort study in a regional cancer centre in India[J]. BrJ Cancer, 2007, 96(7), 1107-1111.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部